¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Receptor, Nerve Growth Factor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • relaxing factor
    ÀÌ¿ÏÀÎÀÚ
  • radiation weighting factor
    ¹æ»ç¼±°¡Áß°è¼ö
  • resistance factor
    ³»¼ºÀÎÀÚ, ÀúÇ×ÀÎÀÚ
  • resistance transfer factor
    ³»¼ºÀü´ÞÀÎÀÚ
  • reticuloendothelial depressant factor
    ±×¹°³»Çǰè¾ïÁ¦ÀÎÀÚ, ¸Á»ó³»Çǰè¾ïÁ¦ÀÎÀÚ
  • rheumatoid factor
    ·ù¸¶Æ¼½ºÀÎÀÚ
  • risk factor
    À§ÇèÀÎÀÚ
  • roentgen-to-rad conversion factor
    ·ÛÆ®°Õ´ë·¡µåº¯È¯°è¼ö
  • somatotropin release inhibiting factor
    ¼ºÀåÈ£¸£¸óºÐºñ¾ïÁ¦ÀÎÀÚ
  • spreading factor
    È®»êÀÎÀÚ
  • stable factor
    ¾ÈÁ¤ÀÎÀÚ
  • scatter factor
    »ê¶õ°è¼ö
  • stroma factor
    ¹öÆÀÁúÀÎÀÚ, °£ÁúÀÎÀÚ
  • sunprotective factor
    Àϱ¤º¸È£Áö¼ö
  • sebotropic factor
    Áö·çÃËÁøÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • therapeutic gain factor
    Ä¡·áÀ̵æ°è¼ö
  • thyrotrophin releasing factor
    ¹æÆÐ»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ, °©»ó»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ
  • time-dose factor
    ½Ã°£¼±·®ÀÎÀÚ
  • tissue factor
    Á¶Á÷ÀÎÀÚ
  • transfer factor
    Àü´ÞÀÎÀÚ
  • transmission factor
    Åõ°ú°è¼ö
  • tumor angiogenesis factor
    Á¾¾çÇ÷°üÇü¼ºÀÎÀÚ
  • tumor necrosis factor
    Á¾¾ç±«»çÀÎÀÚ
  • vascular permeability factor
    Ç÷°üÅõ°úÀÎÀÚ
  • virulence factor
    µ¶¼ºÀÎÀÚ, ¹ßº´ÀÎÀÚ
  • virus inhibitory factor
    ¹ÙÀÌ·¯½º¾ïÁ¦ÀÎÀÚ
  • abducent nerve
    °¡µ¹¸²½Å°æ, ¿ÜÇâ½Å°æ
  • accelerator nerve
    ÃËÁø½Å°æ
  • accessory nerve
    ´õºÎ½Å°æ
  • acoustic nerve
    (¢¡vestibulocochlear nerve) ¼Ó±Í½Å°æ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • platelet-activating factor (PAF)
    Ç÷¼ÒÆÇ Ȱ¼ºÈ­ÀÎÀÚ
  • platelet-activating factor (paf)
    Ç÷¼ÒÆÇȰ¼ºÈ­ÀÎÀÚ(úìá³÷ùüÀàõûùì×í­)
  • power factor
    Ãâ·Â·ü(õóæ³ëÒ), ¿ª·ü(æ³ëÒ).
  • predisposing factor
    ¼ÒÀμº ¿äÀÎ, ¼±Çà¿äÀÎ.
  • prognostic factor
    ¿¹ÈÄÀÎÀÚ
  • prolactin inhibiting factor
    ÇÁ·Ñ¶ôƾ(ºÐºñ)¾ïÁ¦ÀÎÀÚ.
  • prolactin inhibiting factor
    ÇÁ·Î¶ôƾ¾ïÁ¦ÀÎÀÚ
  • prolactin-inhibitory factor(PIF)
    ÇÁ·Î¶ôƾ ºÐºñ ¾ïÁ¦ ÀÎÀÚ
  • prolactin-releasing factor(PRF)
    ÇÁ·Î¶ôƾ ºÐºñ À¯¹ß ÀÎÀÚ
  • protein synthesis factor
    ´Ü¹éÇÕ¼ºÀÎÀÚ(Ó±ÛÜùêà÷ì×í­).
  • psychogenic factor
    ½ÉÀμº ¿ä¼Ò(¡­é©áÈ).
  • psychological factor
    ½É¸®Àû ¿äÀÎ
  • psychosocial factor
    ½É¸®»çȸÀû ¿äÀÎ
  • quality factor
    Á¤¼ºÀÎÀÚ(ïÒàõì×í­).
  • quality factor
    ¼±Áú°è¼ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • macroadenoma,growth hormone-secreting
    ¼ºÀåÈ£¸£¸ó ºÐºñ¼º(à÷íþ¡­ ÝÂÝôàõ)
  • maximal growth rate
    ÃÖ´ëÁõ½ÄÀ²
  • maximum stationary phase (of growth)
    (Áõ½Ä)±Ø´ëÁ¤Áö±â(ñòãÖпÓÞïÎò­Ñ¢).
  • membranous bone growth
    ¸·»ó°ñ ¼ºÀå(دßÒÍéà÷íþ).
  • membranous bone growth
    ¸·»ó°ñ¼ºÀå(¡­ßÒÍéà÷íþ)
  • new growth
    ½Å»ý¼º.(º´¸®)½Å»ý¹°(ãæßæÚª).
  • new growth
    ½Å»ý¼º(ãæßæàõ).½Å»ý¹°(ãæßæÚª)
  • occupational growth
    Á÷¾÷Àû ¼ºÀå (ÊÙËøËÛËö).
  • one step growth
    ÀÏ´ÜÁõ½Ä(ìéÓ«ñòãÖ).
  • one step growth curve
    ÀÏ´ÜÁõ½Ä°î¼±(¡­ÍØàÊ).
  • one step growth experiment
    ÀÏ´ÜÁõ½Ä½ÇÇè(¡­ãùúÐ).
  • organotypic growth
    ±â°üÇüÀû ¼ºÀå(ÐïίúþîÜà÷íþ)
  • pathologic growth
    º´Àû¼ºÀå(Ü»îÜà÷íþ)
  • phase, growth
    Áõ½Ä±â
  • physical growth
    ½Åü¹ßÀ°(ãóô÷Û¡ëÀ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • thyrotropic hormone releasing factor
    °©»ó¼±ÀÚ±Ø(Ë£ßÒàÍí©Ð½) È£¸£¸ó À¯¸®ÀÎÀÚ(ë´×îì×í­)
  • time factor effect
    ½Ã°£ÀÎÀÚ È¿°ú (ãÁÊàì×í­üùÍý)
  • tissue factor
    Á¶Á÷ÀÎÀÚ (ðÚòÄì×í­)
  • transfer factor
    "ÀüÀÌ(ï®ì¹) ÀÎÀÚ(ì×í­), Àü´ÞÀÎÀÚ(îîÓ¹ì×í­)"
  • translocation factor
    ÀüÀ§ ÀÎÀÚ(ï®êÈì×í­)
  • TR factor
    TR ÀÎÀÚ(ì×í­)
  • tumor necrosis factor
    Á¾¾ç ±«»çÀÎÀÚ(ðþåËÎÕÞÝì×í­)
  • two-factor cross
    ÀÌÀÎÀÚ ±³Â÷(ì£ì×í­Îßó©)
  • van't Hoff factor
    ¹ÝÆ® È£ÇÁ ÀÎÀÚ(ì×í­)
  • von Willebrand factor
    Æù ºô·¹ºê¶õÆ® ÀÎÀÚ (ì×í­)
  • Willebrand factor
    ºô·¹ºê¶õÆ® ÀÎÀÚ (ì×í­)
  • xathine oxidase factor
    À鯾 ¿Á½Ãµ¥À̽º ÀÎÀÚ(ì×í­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
ECGF endothelial cell growth factor
EGDF embryonic growth and development factor
EGF epidermal growth factor
EGF-URO epidermal growth factor, urogastrone
FDGF fibroblast-derived growth factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
FGF4 Fibroblast Growth Factor-4
Fgf8 Fibroblast Growth Factor-8
FGF3 Fibroblast growth factor 3
FGF-5 Fibroblast growth factor 5
FGF-9 Fibroblast growth factor 9
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cerebral nerve
    ³ú ½Å°æ
    ³ú·ÎºÎÅÍ ³ª¿À´Â ¸»ÃʽŰæ. ô¼ö·ÎºÎÅÍ ³ª¿À´Â ô¼ö ½Å°æ°ú ´õºÒ¾î ³ú ô¼ö ½Å°æÀ̶ó°íµµ ÇÏ¸ç ¸»ÃʽŰæ°èÀÌ´Ù. ÀÌ¿¡ ´ëÇØ¼­ ³ú¿Í ô¼ö´Â ÁßÃ߽Űæ°è¸¦ ÀÌ·é´Ù. ÀÌ·¯ÇÑ ºÐ·ù´Â ÁÖ·Î ÇüÅ»óÀÇ ±¸ºÐÀÌ´Ù. ³ú ½Å°æÀº ÆÄÃæ·ù ÀÌ»óÀÇ µ¿¹°¿¡¼­´Â 12½Ö, ¿ø±¸·ù´Â 8½Ö, ¾î·ù¿Í ¾ç¼­·ù´Â 10½ÖÀÌ´Ù. »ç¶÷Àº 12½ÖÀÌ Àִµ¥, ÀÌÁß 11½ÖÀº ³úÀÇ ¹Ø ºÎºÐ ¶Ç´Â ¿· ºÎºÐÀ¸·ÎºÎÅÍ, 1½Ö¸¸Àº ³úÀÇ µÞ ºÎºÐ¿¡¼­ ³ª¿Í ÀÖ´Ù. ÇØºÎÇÐÀÚÀÎ °¥·¹³ë½º´Â 7½ÖÀÇ ³ú½Å°æÀÌ ÀÖ´Ù°í ÇÏ¿´°í, T. Àª¸®½º´Â 10½ÖÀÌ ÀÖ´Ù°í Çߴµ¥, ÀÌ »ý°¢ÀÌ ±× ÈÄ ¿À·§µ¿¾È ÇÐȸ¿¡¼­ ¹Þ¾Æµé¿©Á³´Ù. ³ú ½Å°æÀÌ 12½ÖÀ̶ó°í ÇÑ »ç¶÷Àº S. Á¦¸Þ¸µÀÌ´Ù. ³ú ½Å°æ¿¡´Â Áö°¢ ¼¶À¯¸¸À¸·Î µÈ °Í, ¿îµ¿¼¶À¯¸¸À¸·Î ±¸¼ºµÈ °Í, ¶Ç µÎ ¼¶À¯¸¦ ÇÔ²² Æ÷ÇÔÇÑ °Í µîÀÌ ÀÖ´Ù. 12½ÖÀÇ ³ú½Å°æÀº ¾ÕÂÊÀ¸·ÎºÎÅÍ Á¦ 1³ú½Å°æ¿¡¼­ Á¦ 12³ú½Å°æ±îÁö ¹è¿­µÇ¾î ÀÖÀ¸¸ç, °¢°¢ °íÀ¯À̸§ÀÌ ÀÖ´Ù. Áï, ¨ç ÈĽŰæ, ¨è ½Ã½Å°æ, ¨é µ¿¾È½Å°æ, ¨ê ȰÂ÷½Å°æ, ¨ë »ïÂ÷½Å°æ, ¨ì ¿ÜÀü½Å°æ, ¨í ¾È¸é½Å°æ, ¨î û½Å°æ, ¨ï ¼³ÀνŰæ, ¨ð ¹ÌÁֽŰæ, ¨ñºÎ½Å°æ, ¨ò ¼³ÇÏ½Å°æ µîÀÌ´Ù. ÀÌ °¡¿îµ¥¼­ Á¦ 4³ú½Å°æ¸¸ÀÌ ³úÀÇ µÚÂÊÀ¸·ÎºÎÅÍ ³ª¿Í ÀÖ´Ù. ¡¼±â´É¡½ ÈĽŰæÀº Èİ¢À» ´ã´çÇÏ´Â ½Å°æÀ¸·Î, ºñ°­ »óºÎÀÇ Á¡¸· ¾È¿¡ ÀÖ´Â °¨°¢ ¼¼Æ÷ÀÎ ÈO÷¿¡¼­ ³ª¿Â °¡´À´Ù¶õ ¼¶À¯À̸ç, »ç°ñ ±¸¸ÛÀ» ÅëÇÏ¿© ÀüµÎ°³¿Í¿¡ µé¾î°¡ ³úÀÇ Èı¸¿¡±îÁö À̸¥´Ù. ÀÌ¿Í °°ÀÌ °¨°¢ ¼¼Æ÷ÀÇ µ¹±â°¡ Á÷Á¢ ÁßÃß¿¡ µé¾î°£ °ÍÀº »ç¶÷ ¸ö¿¡¼­´Â ÀÌ ¼¼Æ÷»ÓÀÌ´Ù. ½Ã½Å°æÀº ½Ã°¢À» ´ã´çÇÏ´Â ½Å°æÀ̸ç, ¸Á¸· ³»ÀÇ ½Å°æ¼¼Æ÷¿¡¼­ ³ª¿Â ¼¶À¯°¡ ¸ð¿©¼­ ÀÌ·ç¾îÁø´Ù. µ¿¾È½Å°æÀº ¾È±¸¸¦ ¿òÁ÷ÀÌ´Â ¾È±Ù °¡¿îµ¥ »óÁ÷±Ù, ÇÏÁ÷±Ù, ³»Á÷±Ù, ÇÏ»ç±Ù, »ó¾È°Ë°Å±ÙÀ» Áö¹èÇÏ´Â ¿îµ¿½Å°æÀÌ ÁÖÀ̸ç, ±× ¹Û¿¡ µ¿°øÀÇ Ãà¼Ò¸¦ ´ã´çÇÏ´Â ºÎ±³°¨½Å°æµµ Æ÷ÇԵȴÙ. ȰÂ÷½Å°æÀº ¾È±ÙÀÇ »ó»ç±Ù¸¸À» Áö¹èÇÏ´Â ¿îµ¿½Å°æÀÌ´Ù. »ïÂ÷½Å°æÀº Áö°¢ºÎ¿Í ¿îµ¿ºÎ·Î µÈ È¥ÇսŰæÀ¸·Î ³ú ½Å°æ¿¡¼­´Â °¡Àå ±½´Ù. ¾È¸é½Å°æÀº ±³¿Í ¿¬¼öÀÇ °æ°è·ÎºÎÅÍ ³ª¿Â °ÍÀ̸ç, ´ëºÎºÐÀÌ ¿îµ¿½Å°æÀ¸·Î ¾È¸éÀÇ Ç¥Á¤±ÙÀ» Áö¹èÇÑ´Ù. û½Å°æÀº ÀüÁ¤½Å°æ°ú ¿Í¿ì½Å°æÀ¸·Î ³ª´©¾îÁ® ¿¬¼ö·ÎºÎÅÍ ³ª¿Â´Ù. ÀüÁ¤½Å°æÀº ³»ÀÌ
  • cervical nerve root
    °æºÎ ½Å°æ±Ù
  • chorda tympani nerve
    °í½Ç ½Å°æ
    º×²ÀÁö ±¸¸ÛÀÇ À­ ºÎÀ§¿¡¼­ ¾È¸é ½Å°æÀ¸·ÎºÎÅÍ °¥¶óÁ® ³ª¿Í °í½Ç·Î µé¾î°£´Ù. ÀÌ¾î °í¸· ³»Ãø¸éÀÇ ¸ÁÄ¡»À¿Í ¸ð·ç»À »çÀ̸¦ Áö³ª ¹ÙÀ§°í½Ç Æ´»õ¸¦ °ÅÃÄ ÅΰüÀýÀÇ ³»ÃøÀ¸·Î ³ª¿À¸ç, À̾ °üÀÚ ¾Æ·¡ ¿ì¹¬¿¡¼­ ¼³ ½Å°æ°ú ÇÕÃÄÁø´Ù.
  • chromatophore nerve
    »ö ¼ÒÆ÷ ½Å°æ
    µ¿¹°Ã¼ÀÇ ÇǺΠ¼Ó¿¡ ÀÖ´Â »ö¼Ò ¼¼Æ÷ÀÇ È°µ¿À» Áö¹èÇÏ´Â ½Å°æ. »ö¼Ò ¼¼Æ÷ ³»ÀÇ »ö¼Ò °ú¸³À» È®»ê ¶Ç´Â ÀÀÁý½ÃŰ°Å³ª, ¶Ç´Â »ö ¼ÒÆ÷ÀÇ ¹Ù±ù µÑ·¹¿¡ ¹æ»ç»óÀ¸·Î ºÙ´Â »ö¼ÒÆ÷ ±ÙÀ» ¼öÃà ¶Ç´Â À̿ϽÃÄÑ µ¿¹°ÀÇ Ã¼»öÀ» º¯È­½ÃŲ´Ù. ü»öÀÇ ¾ÏÈ­¸¦ À§ÇÑ ½Å°æ°ú ¸íÈ­¸¦ À§ÇÑ ½Å°æÀÌ °øÁ¸ÇÏ´Â °æ¿ì¸¦ º¹½Å°æ¼º, ÇÑÂʸ¸ ÀÖ´Â °æ¿ì¸¦ ´Ü½Å°æ¼ºÀ̶ó°í ÇÑ´Ù. µ¿¹°ÀÇ Á¾·ù¿¡ µû¶ó ¿©·¯ °¡Áö°¡ Àִµ¥, ¿À¡¾î, ¹®¾î¿Í °°Àº µÎÁ··ùÀÇ °æ¿ì´Â »ö¼ÒÆ÷ ±ÙÀ» Á÷Á¢ Áö¹èÇϰí, ¶ÇÇÑ ±ÙÀ°ÀÇ ¼öÃà°ú ¾ïÁ¦¸¦ Áö¹èÇÏ´Â ÀÌÁß Áö¹èÀ̹ǷΠ¹ÝÀÀÀº ¸î Ãʳ»¿¡ ¿Ï·áµÇ¸ç, ü»ö º¯È­°¡ ¸Å¿ì ½Å¼ÓÇÏ°í ¶ÇÇÑ ¶Ñ·ÇÇÏ´Ù. °æ°ñ¾î·ù¿¡¼­´Â »ö¼ÒÆ÷ ³»¿¡¼­ÀÇ »ö¼Ò °ú¸³ÀÇ ÀÀÁý°ú È®»ê¿¡ ÀÇÇÏ¿© ü»öÀÌ º¯È­Çϴµ¥, ±³°¨½Å°æ°è¿¡ ¼ÓÇÏ´Â ÀÀÁý¼º ½Å°æ°ú ºÎ±³°¨½Å°æ°è¿¡ ¼ÓÇÏ´Â È®»ê¼º ½Å°æÀÇ ÀÌÁß Áö¹è¸¦ ¹Þ´Â´Ù. ¿¬°ñ ¾î·ù¿Í ÆÄÃæ·ùÀÇ Ä«¸á·¹¿ÂÀº ÀÀÁý¸¸ÀÌ ½Å°æÀÇ Áö¹è¸¦ ¹Þ´Â ´Ü½Å°æ¼ºÀÌ´Ù. ü»ö º¯È­´Â ½Å°æÀÇ Áö¹è¿¡ ÀÇÇÑ °æ¿ì ¿Ü¿¡ È£¸£¸óÀÇ ÀÛ¿ë¿¡ ÀÇÇÑ °æ¿ìµµ ¸¹´Ù.
  • communicating branch with facial nerve
    ¾ó±¼ ½Å°æÀý°úÀÇ ±³Åë °¡Áö, ¾È¸é ½Å°æÀý°úÀÇ ±³ÅëÁö
  • cranial nerve
    µÎ°³ ½Å°æ, ³ú½Å°æ
    ³ú·ÎºÎÅÍ ±â¿øµÇ´Â 12½ÖÀÇ ½Å°æ.
  • cranial nerve examination
    ³ú½Å°æ °Ë»ç
  • cranial nerve syndrome
    ³ú½Å°æ ÁõÈıº
  • cutaneous nerve
    ÇǺΠ½Å°æ, ÇÇ ½Å°æ
  • deep temporal nerve
    ±íÀº °üÀڽŰæ, ½ÉÃøµÎ ½Å°æ
    ¿ÜÃø À͵¹±ÙÀÇ À§¸é¿¡¼­ ¾Õ, µÚÀÇ 2°¡Áö·Î ³ª´µ¾î¼­ ÃøµÎ±Ù¿¡ µé¾î°¡´Â ½Å°æ.
  • dorsal branch of ulnar nerve
    Àڽаæ¼Õ µî°¡Áö
  • dorsal nerve
    ¹èºÎ ½Å°æ
  • dorsal nerve of penis
    À½°æ µî½Å°æ
  • dorsal scapular nerve
    µîÂÊ ¾î±ú ½Å°æ
  • efferent nerve
    ¿ø½É¼º ¼¶À¯, ¿ø½É¼º ½Å°æ
    1. ³ú, ô¼ö¿¡¼­ ³ª¿À´Â ½Å°æÀ¸·Î ÁßÃ߽Űæ°è·ÎºÎÅÍ ±ÙÀ°, »ù, ³»Àå Àå±â¿¡ ÀÓÆÞ½º¸¦ Àü´Þ. 2. Ãæ°ÝÀ» ÁßÃ߽Ű濡¼­ ¸»ÃÊÀÇ È¿°ú±â·Î º¸³»´Â ½Å°æ. 3. ÁßÃ߽Űæ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
B-cell differentiating factor <cytokine> A soluble cytokine factor produced by activated T-lymphocytes that promotes antibody production by causing proliferation and differentiation of B-cells.
Interleukin-4 induces the expression of class II major histocompatibility complex and fc receptors on B-cells. It also acts on T-lymphocytes, mast cell lines, and several other haematopoietic lineage cells including granulocyte, megakaryocyte, and erythroid precursors, as well as macrophages.
Acronym: IL-4
(12 Dec 1998)
B-cell stimulatory factor 2 <cytokine> A cytokine that stimulates the growth and differentiation of human B-cells and is also a growth factor for hybridomas and plasmacytomas.
It is produced by many different cells including T-cells, monocytes, and fibroblasts. A single chain 25 kD cytokine originally described as a pre B-cell growth factor, now known to have effects on a number of other cells including T-cells which are also stimulated to proliferate.
An inducer of acute phase proteins and a colony-stimulating factor acting on mouse bone marrow.
Acronym: IL-6
(12 Dec 1998)
bifidus factor An unidentified substance associated with Lactobacillus bifidus subsp. Pennsylvanicus, present in mammalian milk.
(05 Mar 2000)
bioaccumulation factor Concentration of a chemical in living tissue divided by its concentration in the animal's diet.
(09 Oct 1997)
bioconcentration factor Concentration of a chemical in an organism divided by its concentration in the test solution or environment (for example, concentration in fish divided by concentration in water).
(09 Oct 1997)
Bittner's milk factor Member of the retrovirus subfamily Oncornavirinae, antigenically distinct from the murine leukaemia-sarcoma complex, that is associated with adenocarcinomatous tumours of the mammary gland, commonly latent in wild and laboratory mice and causing cancer only in genetically susceptible strains under certain hormonal influences.
Synonym: Bittner agent, Bittner virus, Bittner's milk factor, mammary cancer virus of mice, milk factor, mouse mammary tumour virus.
(05 Mar 2000)
blood clotting factor <haematology> Any of a number of different protein factors which, when acting together, can form a blood clot shortly after platelets have broken at the site of the wound.
The factors have Roman numeral names, like VII, VIII, IX, X, XI, and XIII. Defects in the genes which code for any of these factors result in genetic diseases like haemophilia, which results from a defect in the gene for factor VIII or IX.
(09 Oct 1997)
blood coagulation factor inhibitors Substances, usually endogenous, that act as inhibitors of blood coagulation. They may affect one or multiple enzymes throughout the process. As a group, they also inhibit enzymes involved in processes other than blood coagulation, such as those from the complement system, fibrinolytic enzyme system, blood cells, and bacteria.
(12 Dec 1998)
brain-derived neurotrophic factor <growth factor> Small basic protein purified from pig brain, a member of the family of neurotrophic factors that also includes Nerve Growth Factor and neurotrophin 3.
In contrast to nerve growth factor, brain-derived neurotrophic factor is predominanantly (though not exclusively) localised in the CNS. It supports the survival of primary sensory neurons originating from the neural crest and ectodermal placodes that are not responsive to NGF.
In the brain brain-derived neurotrophic factor has a trophic action on retinal, cholinergic, and dopaminergic neurons, and in the peripheral nervous system it acts on both motor and sensory neurons.
Acronym: BDGF
(12 Dec 1998)
branching factor 1,4-alpha-glucan-branching enzyme.
(05 Mar 2000)
BT factor <biochemistry> _ Hydroxy _ trimethyl aminobutyric acid. Compound that transports long chain fatty acids across the inner mitochondrial membrane in the form of acyl carnitine. Sometimes referred to as Vitamin Bt or Vitamin B7.
(18 Nov 1997)
CAMP factor A test to identify Group B beta-streptococci based on their formation of a substance (CAMP factor) that enlarges the area of haemolysis formed by streptococcal beta-haemolysin.
Origin: Christie, Atkins, and Munch-Petersen, developers of the t.
(05 Mar 2000)
capacity factor <physics> This is the ratio of the average power output from an electric power plant to the plant's rated capacity. A capacity factor is ideally unity, but invariably less. Capacity factors vary widely between types of electric plants (for example, nuclear, solar, coal, etc.), and can even vary widely for a single type of power plant.
<radiobiology> Index (typically in percent) indicating the average power supplied by an energy plant, relative to its maximum rated capacity.
Synonym: plant factor, load factor.
(13 Jan 1998)
capillary permeability factor A mixture of bioflavonoids extracted from plants (especially citrus fruits). It reduces the permeability and fragility of capillaries and is useful in the treatment of certain cases of purpura that are resistant to vitamin C therapy.
See: hesperidin, quercetin, rutin.
Synonym: capillary permeability factor, citrin, permeability vitamin.
(05 Mar 2000)
galactagogue factor <endocrinology> A factor in extracts of the posterior lobe of the hypophysis that, by stimulating the smooth muscle of the lobulo-alveolar system of the mammary gland, causes a flow of milk from the nipple.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á